CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 228 enrolled
Drug / intervention
Tecnis Eyhance +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05025345
NCT05025345N/ACompleted

Clinical Evaluation of the Vision Performance of TECNIS EYHANCE™ Intraocular Lenses With TECNIS SIMPLICITY™ as Compared to TECNIS® 1-piece Intraocular Lenses

Johnson & Johnson Surgical Vision, Inc.·interventional·Posted Aug 27, 2021·Updated Aug 28, 2023

In Brief

A clinical study evaluating Tecnis Eyhance and Tecnis 1 piece IOL for Cataract. Completed, enrolled 228 participants across 15 sites.

Detailed Summary

This study is a 6-month, prospective, multicenter, bilateral, randomized subject- and evaluator-masked, clinical investigation of the TECNIS Eyhance IOL versus the TECNIS 1-piece IOL. The study will be conducted at up to 15 sites in the U.S.A and will enroll approximately 220 subjects to achieve approximately 200 randomized and bilaterally implanted subjects, resulting in approximately 100 evaluable subjects in each lens group at 6 months. Subjects are to be implanted with the same IOL in both eyes: TECNIS Eyhance IOL or the TECNIS 1-Piece IOL. The eye implanted first will be considered the primary study eye.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedAug 27, 2021
Enrollment StartSep 2, 2021
Primary CompletionJun 17, 2022
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 4.8 years ago

Interventions

Tecnis Eyhancedevice

Investigational intraocular lens replaces the natural lens removed during cataract surgery in both eyes.

Tecnis 1 piece IOLdevice

Control intraocular lens replaces the natural lens removed during cataract surgery in both eyes.